These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36175948)

  • 21. Prevention and Control of Multidrug-Resistant Gram-Negative Bacteria in Adult Intensive Care Units: A Systematic Review and Network Meta-analysis.
    Teerawattanapong N; Kengkla K; Dilokthornsakul P; Saokaew S; Apisarnthanarak A; Chaiyakunapruk N
    Clin Infect Dis; 2017 May; 64(suppl_2):S51-S60. PubMed ID: 28475791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the "Zero Resistance" program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study.
    Álvarez-Lerma F; Catalán-González M; Álvarez J; Sánchez-García M; Palomar-Martínez M; Fernández-Moreno I; Garnacho-Montero J; Barcenilla-Gaite F; García R; Aranaz-Andrés J; Lozano-García FJ; Ramírez-Galleymore P; Martínez-Alonso M
    Med Intensiva (Engl Ed); 2023 Apr; 47(4):193-202. PubMed ID: 36670011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance study of bloodstream infections, antimicrobial use, and resistance patterns among intensive care unit patients: A retrospective cross-sectional study.
    Ababneh MA; Al Domi M; Rababa'h AM
    Int J Crit Illn Inj Sci; 2022; 12(2):82-90. PubMed ID: 35845122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation and outcomes of hospital-wide computerized antimicrobial approval system and on-the-spot education in a traumatic intensive care unit in Taiwan.
    Huang TY; Hung CH; Lai LJ; Chuang HJ; Wang CC; Lin PT; Hsu WH
    J Microbiol Immunol Infect; 2018 Oct; 51(5):672-680. PubMed ID: 29167061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison.
    Lai CC; Shi ZY; Chen YH; Wang FD
    J Microbiol Immunol Infect; 2016 Feb; 49(1):74-82. PubMed ID: 26586483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia.
    Seligman R; Ramos-Lima LF; Oliveira Vdo A; Sanvicente C; Sartori J; Pacheco EF
    J Bras Pneumol; 2013; 39(3):339-48. PubMed ID: 23857697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial stewardship in the intensive care unit.
    Ture Z; Güner R; Alp E
    J Intensive Med; 2023 Jul; 3(3):244-253. PubMed ID: 37533805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico.
    Uc-Cachón AH; Gracida-Osorno C; Luna-Chi IG; Jiménez-Guillermo JG; Molina-Salinas GM
    Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31540314
    [No Abstract]   [Full Text] [Related]  

  • 29. Antimicrobial De-Escalation in the ICU: From Recommendations to Level of Evidence.
    Lakbar I; De Waele JJ; Tabah A; Einav S; Martin-Loeches I; Leone M
    Adv Ther; 2020 Jul; 37(7):3083-3096. PubMed ID: 32462606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.
    Pierson CL; Friedman BA
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):19S-30S. PubMed ID: 1737439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis and comparison of cumulative antibiograms for the Charlotte Maxeke Johannesburg Academic Hospital adult intensive care and high-care units, 2013 and 2017.
    Law T; Chibabhai V; Nana T
    S Afr Med J; 2019 Dec; 110(1):55-64. PubMed ID: 31865944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for excessively prolonged meropenem use in the intensive care setting: a case-contol study.
    Katchanov J; Kreuels B; Maurer FP; Wöstmann K; Jochum J; König C; Seoudy K; Rohde H; Lohse AW; Wichmann D; Baehr M; Rothe C; Kluge S
    BMC Infect Dis; 2017 Feb; 17(1):131. PubMed ID: 28178922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bloodstream infections in critically ill patients: an expert statement.
    Timsit JF; Ruppé E; Barbier F; Tabah A; Bassetti M
    Intensive Care Med; 2020 Feb; 46(2):266-284. PubMed ID: 32047941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Adverse Effects of Broad-Spectrum Antimicrobial Exposure in the Intensive Care Unit.
    Wiens J; Snyder GM; Finlayson S; Mahoney MV; Celi LA
    Open Forum Infect Dis; 2018 Feb; 5(2):ofx270. PubMed ID: 29479546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control.
    Cheon S; Kim MJ; Yun SJ; Moon JY; Kim YS
    Korean J Intern Med; 2016 Mar; 31(2):367-74. PubMed ID: 26874513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare-Associated Infections in Pediatric and Neonatal Intensive Care Units: Impact of Underlying Risk Factors and Antimicrobial Resistance on 30-Day Case-Fatality in Italy and Brazil.
    Folgori L; Bernaschi P; Piga S; Carletti M; Cunha FP; Lara PH; de Castro Peixoto NC; Alves Guimarães BG; Sharland M; Araujo da Silva AR; Ciofi Degli Atti M
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1302-1309. PubMed ID: 27511591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial use for treatment of healthcare-associated infections and bacterial resistance in a reference neonatal unit.
    Silva ACBE; Anchieta LM; Rosado V; Ferreira J; Clemente WT; Coelho JS; Mourão PHO; Romanelli RMC
    J Pediatr (Rio J); 2021; 97(3):329-334. PubMed ID: 32592659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nationwide survey of intravenous antimicrobial use in intensive care units in Japan.
    Ohnuma T; Hayashi Y; Yamashita K; Marquess J; Lefor AK; Sanui M;
    Int J Antimicrob Agents; 2018 Apr; 51(4):636-641. PubMed ID: 29408737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial.
    Leone M; Bechis C; Baumstarck K; Lefrant JY; Albanèse J; Jaber S; Lepape A; Constantin JM; Papazian L; Bruder N; Allaouchiche B; Bézulier K; Antonini F; Textoris J; Martin C;
    Intensive Care Med; 2014 Oct; 40(10):1399-408. PubMed ID: 25091790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.